Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

60%

3 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
2(50.0%)
Phase 4
1(25.0%)
N/A
1(25.0%)
4Total
Phase 3(2)
Phase 4(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT00126958Unknown

Cost-Effectiveness in Bladder Cancer

Role: collaborator

NCT00214643Phase 3Completed

Efficacy of Fosmidomycin-Clindamycin for Treating Malaria in Gabonese Children

Role: lead

NCT00270673Phase 3Completed

Early Lactate-Directed Therapy in the Intensive Care Unit (ICU)

Role: collaborator

NCT00566436Not ApplicableUnknown

Remote Endarterectomy Versus Suprageniculate Femoropopliteal Bypass

Role: collaborator

NCT00453856Phase 4Terminated

Efficacy of Sulfadoxine-Pyrimethamine for Treating Malaria in Gabonese Children

Role: lead

All 5 trials loaded